Ultrasound therapy.....New testing approach for Lyme disease: Ultrasound and PCR urine testing
Lyme disease is notoriously difficult to test for.
Lyme is highly compartmentalized. That means it sets up sanctuaries in different body compartments, and chronic Lyme is not living in the blood. Lyme may be in the blood in acute Lyme but not in chronic Lyme.
In chronic Lyme it may be in the right hippocampus but not in the entire brain, maybe in the brain stem but not the liver. It may be in your disk of L4-L5 but not in other disks and so on and so forth.
It lives in biofilm. We know that. It lives in the cell, but it doesn’t stray.
He goes on to share that the common immune system-based Lyme disease tests that use blood testing are misleading because with chronic Lyme,
“the blood or the white blood cells are not in contact with the actual microbes and you do not get the immune activation…So many cases go undiagnosed.”
Dr. Klinghardt shares a wonderful technique that he and one of the world’s most renowned ultrasound radiologists, Dr. Marco Ruggiero, have developed for both testing and to improve treatment:
Put ultrasound on the brain, on the thymus, on the spleen, on the vagus nerve, and on the brain stem. We drive out the microbes, and then we collect the urine and find the microbes. This is by far the best test we use – the PCR testing – looking for whole strands of DNA of the bugs in the urine.
He goes on to explain how they also use the therapeutic ultrasound as an instrument to optimize drug uptake and utilization in specific areas of the body order to eliminate the bacteria.
Ruggiero-Klinghardts protocol was initially developed for persistent Lyme disease, it shows significant potential in conditions ranging from cancer to neurodegenerative diseases and autism.
Thus, the 1st goal of the RK Protocol is diagnostic: That is, to make pathogens, toxins, transformed cells and cells infected by viruses that are inaccessible to conventional diagnostic and therapeutic tools, "visible" to the therapist who can detect them with laboratory methods and deal with them with appropriate interventions; and also to make them "visible" to the immune system that can fight them in a physiological manner. The 2nd goal is to optimize drug uptake and utilization in the organs and tissues studied and targeted with these procedures.
Lyme disease is notoriously difficult to test for.
Lyme is highly compartmentalized. That means it sets up sanctuaries in different body compartments, and chronic Lyme is not living in the blood. Lyme may be in the blood in acute Lyme but not in chronic Lyme.
In chronic Lyme it may be in the right hippocampus but not in the entire brain, maybe in the brain stem but not the liver. It may be in your disk of L4-L5 but not in other disks and so on and so forth.
It lives in biofilm. We know that. It lives in the cell, but it doesn’t stray.
He goes on to share that the common immune system-based Lyme disease tests that use blood testing are misleading because with chronic Lyme,
“the blood or the white blood cells are not in contact with the actual microbes and you do not get the immune activation…So many cases go undiagnosed.”
Dr. Klinghardt shares a wonderful technique that he and one of the world’s most renowned ultrasound radiologists, Dr. Marco Ruggiero, have developed for both testing and to improve treatment:
Put ultrasound on the brain, on the thymus, on the spleen, on the vagus nerve, and on the brain stem. We drive out the microbes, and then we collect the urine and find the microbes. This is by far the best test we use – the PCR testing – looking for whole strands of DNA of the bugs in the urine.
He goes on to explain how they also use the therapeutic ultrasound as an instrument to optimize drug uptake and utilization in specific areas of the body order to eliminate the bacteria.
Ruggiero-Klinghardts protocol was initially developed for persistent Lyme disease, it shows significant potential in conditions ranging from cancer to neurodegenerative diseases and autism.
Thus, the 1st goal of the RK Protocol is diagnostic: That is, to make pathogens, toxins, transformed cells and cells infected by viruses that are inaccessible to conventional diagnostic and therapeutic tools, "visible" to the therapist who can detect them with laboratory methods and deal with them with appropriate interventions; and also to make them "visible" to the immune system that can fight them in a physiological manner. The 2nd goal is to optimize drug uptake and utilization in the organs and tissues studied and targeted with these procedures.
